Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
10 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations (NCT02383927) | Kura Oncology, Inc. | 2015-05-13 |
Track Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) automatically
Every clearance here is in the API, with alerts when new ones post.